EVALUACIÓN DE LA PREVALENCIA DE INFECCIÓN POR GÉRMENES ATÍPICOS EN PACIENTES CON NEUMONÍA ADQUIRIDA EN LA COMUNIDAD EN UN HOSPITAL DE REFERENCIA PERUANO: EVALUATION OF THE PREVALENCE OF INFECTION BY ATYPICAL GERMS IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA IN A PERUVIAN REFERENCE HOSPITAL

Alonso Soto

doi:10.25176/RFMH.v19i4.2194

Authors

Alonso Soto Instituto de Investigación en Ciencias Biomédicas. Universidad Ricardo Palma https://orcid.org/0000-0001-8648-8032

DOI:

https://doi.org/10.25176/RFMH.v19i4.2194

Keywords:

Pneumonia, Mycoplasma pneumoniae, Chlamydia pneumoniae

Abstract

Objective: To determine the prevalence of infection due to atypical microorganisms in cases of communityacquired pneumonia in adult inmunocompetent patients seeking attention in the Hospital Nacional Hipolito Unanue. Methods: Adult inmunocompetent patients seeking medical attention in the emergency ward of Hospital Hipolito Unanue with diagnosis of community-acquired pneumonia were evaluated between september 2008 and january 2009. Blood samples were drawn for Mycoplasma pneumoniae and Chlamydia pneumoniae serology, by the detection of M Inmunoglobulin by ELISA technique. Results: We recruited 85 patients. The average age was 65.33 ± 21.43 years. We found 3 cases with positive IgM serology against M. pneumoniae and 1 case positive against C. pneumoniae. The antibody titers against M. pneumoniae had a highly significant correlation with the age (r=-0.28; p<0.01). We also found a statistically significant difference between the titers of antibodies against M. pneumoniae and those correspondent to C. pneumoniae (r=0.29; p<0.01). Conclusion: Infection due to atypical microorganisms doesn’t seem to be a frequent condition in inpatients with diagnosis of community-acquired pneumonia. Research in larger populations, including outpatients should be done, in order to define the role of atypical pathogens in cases of pneumonia at a national level.

Downloads

Download data is not yet available.

References

1. Lanks CW, Musani AI, Hsia DW. Community-acquired Pneumonia and Hospital-acquired Pneumonia. Med Clin North Am 2019;103(3):487–501.
2. Said MA, Johnson HL, Nonyane BAS, Deloria-Knoll M, O′Brien KL, for the AGEDD Adult Pneumococcal Burden Study Team. Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques. PLoS ONE 2013; 8(4): e60273. https://doi.org/10.1371/journal.pone.0060273
3. Cullotta AR, Kalter HD, Delgado J, et al. Antimicrobial Susceptibilities and Serotype Distribution of Streptococcus pneumoniae Isolates from a Low Socioeconomic Area in Lima, Peru. Clin Vaccine Immunol 2002;9(6):1328–31.
4. Beović B, Bonač B, Keše D, et al. Aetiology and Clinical Presentation of Mild Community-Acquired Bacterial Pneumonia. Eur J Clin Microbiol Infect Dis 2003; 22(10):584–91.
5. Torres A, Blasi F, Peetermans WE, Viegi G, Welte T. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: A literature review. Eur. J. Clin. Microbiol. Infect. Dis. 2014;33(7):1065–79.
6. Lim WS, Baudouin S, George R, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: Update 2009. Thorax 2009;64:iii1-iii5.
7. National Institute for Health and Care Excellence. Diagnosis and management of community- and hospital-acquired pneumonia in adults [Internet]. NICE; 2014 [fecha de acceso 2019 Jul 7]. Disponible en: https://www.nice.org.uk/guidance/cg191/evidence
8. Sociedad Peruana de Enfermedades Infecciosas y tropicalces, Organización Panamericana de la Salud. Neumonía Adquirida en la Comunidad en Adultos [Internet]. Lima: 2009 [fecha de acceso 2019 Jul 7]. Disponible en: http://bvs.minsa.gob.pe/local/minsa/2418.pdf
9. Mandell LA, Wunderink RG, Anzueto A, Bartlett J, Campbell G, Dean N et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis 2007;44: S27–72.
10. Francisco MCJ. Gérmenes atípicos en niños con neumonía adquirida en la comunidad. Acta Médica Peru 2012; 29(1):17–22.
11. Miravitlles M, Grupo de Trabajo de la Asociación Latinoamericana del Tórax (ALAT). Recomendaciones ALAT sobre la neumonía adquirida en la comunidad. Arch Bronconeumol 2013;37(8):340–8.
12. Chen ZR, Yan YD, Wang YQ, Zhu H, Shao XJ, Xu J, et al. Epidemiology of community-acquired Mycoplasma Pneumoniae respiratory tract infections among hospitalized Chinese children, including relationships with meteorological factors. Hipokkratia 2013; 17(1):20-26.
13. Chahin A, Opal SM. Severe Pneumonia Caused by Legionella pneumophila: Differential Diagnosis and Therapeutic Considerations. Infect Dis Clin North Am 2017;31(1):111–21.

14. Richards GA, Brink AJ, Feldman C. Rational use of the fluoroquinolones. South African Med J 2019;109(6):378.
15. Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, et al. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev 2012 [Fecha de acceso 2019 Jul 11];(9). Disponible en: http://doi.wiley.com/10.1002/14651858.CD004418.pub4